▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for American Vanguard in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $20.37.
The current consensus among 0 polled investment analysts is to n/a stock in American Vanguard. This rating has held steady since October 2020, when it changed from a Buy consensus rating.
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. It also markets and distributes end-use chemical and biological products for crop applications; distributes chemicals for greenhouse and nursery production markets; and offers formulations, such as PCNB, chlorothalonil, and propiconazole under the FFII and FFIII names. The company distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. American Vanguard Corporation was founded in 1969 and is headquartered in Newport Beach, California.